CA
CASI Pharmaceuticals, Inc.
CASI · NASDAQ
$0.15 +3.08% (+$0.00)
Market Cap $2.25M
P/E Ratio -
Div. Yield -
ROE 358.32%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.08x
P/E N/A
EV/EBITDA N/A
Growth
78 /100
Growing Rev. growth 118.52%
Book val. growth 15.16%
EPS growth N/A
Profitability
16 /100
Weak Gross margin 35.80%
Net margin 183.93%
Op. margin 167.98%
Quality
44 /100
Average ROIC 1,210.78%
ROE 358.32%
ROA 201.86%
Debt
50 /100
Moderate Current ratio 0.30x
Int. coverage -31.98x
Net debt/EBITDA -0.34x
Stability
48 /100
Moderate Beta 0.89x
Rev. volatility 116.31%
EPS volatility 25.29%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CASI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Cory
Employees
233
Headquarters
Beijing